Basel Medical (BMGL) Cash & Equivalents (2023 - 2025)
Basel Medical (BMGL) posted Cash & Equivalents of $3.0 million for Q4 2025, up 30.17% sequentially from $2.3 million in Q2 2025, and up 56.04% YoY from $2.0 million in Q4 2024.
Powered by 
Analysis
Basel Medical (BMGL) Cash & Equivalents (2023 - 2025) Analysis & Trends
Basel Medical has reported Cash & Equivalents for 2 years, with the latest figure at $3.0 million in Q4 2025.
- Quarterly Cash & Equivalents rose 56.04% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 56.04% YoY) and the FY2025 annual result came in at $2.3 million, up 119.97% from the prior year.
- Cash & Equivalents grew to $3.0 million in Q4 2025 per BMGL's latest filing, from $2.3 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $3.0 million in Q4 2025 and troughed at $1.4 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 89.42 Bn | 88.41 Bn | 15.19 Bn | 1.01 Bn |
| 2 | Tenet Healthcare | 22.09 Bn | 19.92 Bn | 4.45 Bn | 2.17 Bn |
| 3 | Encompass Health | 12.09 Bn | 11.96 Bn | 1.34 Bn | 107.70 Mn |
| 4 | Davita | 11.86 Bn | 11.17 Bn | 1.16 Bn | 668.96 Mn |
| 5 | Universal Health Services | 10.16 Bn | 10.02 Bn | 3.29 Bn | 138.80 Mn |
| 6 | Ensign | 9.92 Bn | 9.60 Bn | 306.24 Mn | 262.30 Mn |
| 7 | Chemed | 6.90 Bn | 6.86 Bn | 221.47 Mn | 40.22 Mn |
| 8 | Pacs | 6.75 Bn | 6.58 Bn | 338.46 Mn | 164.45 Mn |
| 9 | Concentra Group Holdings Parent | 4.31 Bn | 4.15 Bn | 192.10 Mn | 158.04 Mn |
| 10 | Basel Medical | 7.33 Mn | 6.54 Mn | - | 1.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.04 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.22 Mn |